aTyr Pharma disclosed insider trading to the SEC on August 8, 2026, coinciding with Freedom Capital raising its rating on the company and Paul Schimmel purchasing shares.
1 report, 1 independent
Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
aTyr Pharma disclosed insider trading to the SEC on August 8, 2026, coinciding with Freedom Capital raising its rating on the company and Paul Schimmel purchasing shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
aTyr Pharma
company in San Diego, United States
Nothing else this week.
-
SEC
Slovak company
-
Freedom Capital
company in the Czech Republic
Related events
- Multiple financial disclosures on Oct 17 include analyst rating changes, institutional purchases, and insider stock sales.
- Nano Nuclear Energy disclosed insider transactions with the SEC on May 26, 2026, its stock traded on NASDAQ, and Benchmark gave it a buy rating.
- ETF Portfolio Partners Inc. disclosed trading activity to the SEC on October 24, 2026.
- SoFi disclosed insider trades via an SEC filing on October 19, 2026.
- Insider sale disclosed in SEC filing for Global Industrial Company, concurrent with MarketBeat consensus ratings and Benzinga coverage.